INGREZZA Trademark

Trademark Overview


On Tuesday, August 26, 2025, a trademark application was filed for INGREZZA with the United States Patent and Trademark Office. The USPTO has given the INGREZZA trademark a serial number of 99358616. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, January 17, 2026. This trademark is owned by Neurocrine Biosciences, Inc.. The INGREZZA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for the treatment of Huntington's Disease and chorea associated with Huntington's Disease

Providing medical information; providing medical information in the field of neurological, central nervous system, psychiatric and movement diseases, disorders, and conditions; providing medical information in the field of tardive dyskinesia; providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease
ingrezza

General Information


Serial Number99358616
Word MarkINGREZZA
Filing DateTuesday, August 26, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, January 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedThe color(s) pink, orange, and purple is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for human use; pharmaceutical preparations for the treatment of neurological, central nervous system, psychiatric and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for the treatment of Huntington's Disease and chorea associated with Huntington's Disease
Goods and ServicesProviding medical information; providing medical information in the field of neurological, central nervous system, psychiatric and movement diseases, disorders, and conditions; providing medical information in the field of tardive dyskinesia; providing medical information in the field of Huntington's Disease and chorea associated with Huntington's Disease
Description of MarkThe mark consists of a sequence of right pointing arrows colored pink on the left shading into orange and the word "INGREZZA". The “ING” is colored pink on the left shading into orange and the “REZZA” is colored purple. The white in the mark is background and is not claimed as a feature.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 26, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Tuesday, August 26, 2025NEW APPLICATION ENTERED
Tuesday, August 26, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, January 14, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 14, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 15, 2026ASSIGNED TO EXAMINER
Saturday, January 17, 2026NON-FINAL ACTION WRITTEN
Saturday, January 17, 2026NON-FINAL ACTION E-MAILED
Saturday, January 17, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 17, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, February 17, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED